| Michelle M Lizotte, MD | |
|
225 Big Timber Loop Rd, Big Timber, MT 59011-7646 | |
| (406) 932-7100 | |
| (406) 932-7102 |
| Full Name | Michelle M Lizotte |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 225 Big Timber Loop Rd, Big Timber, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124388426 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R-9381 (Iowa) | Secondary |
| 207Q00000X | Family Medicine | 41818 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pioneer Medical Center | Big timber, MT | Hospital |
| Livingston Healthcare | Livingston, MT | Hospital |
| St Vincent Healthcare | Billings, MT | Hospital |
| Entity Name | Crazy Mountain Family Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497357529 PECOS PAC ID: 2264845965 Enrollment ID: O20210118000686 |
News Archive
Olympic athletes inspire us with their fierce discipline and natural talent as they smash records, going higher, further and faster. Their can-do spirit encourages us all to take on new challenges.
Hospital-acquired infections are a huge public health burden, and hospital environments play a key role in harboring potentially deadly bacteria such as E. coli, C. difficile and methicillin-resistant Staphylococcus aureus.
The National Institute on Drug Abuse, part of the National Institutes of Health, has awarded the University of California, Irvine School of Medicine, a 4-year, $9 million grant aimed at determining the long-term impact of cannabis exposure on the adolescent brain.
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D, the company's controlled-release latanoprost insert for the treatment of glaucoma.
The GOP vice presidential candidate made these comments while speaking to a conservative audience at the Values Voter Summit in Washington, D.C. Meanwhile, Planned Parenthood was quick to hit back.
› Verified 8 days ago
| Entity Name | Plushcare Of California Inc A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811378987 PECOS PAC ID: 2365707163 Enrollment ID: O20220222001999 |
News Archive
Olympic athletes inspire us with their fierce discipline and natural talent as they smash records, going higher, further and faster. Their can-do spirit encourages us all to take on new challenges.
Hospital-acquired infections are a huge public health burden, and hospital environments play a key role in harboring potentially deadly bacteria such as E. coli, C. difficile and methicillin-resistant Staphylococcus aureus.
The National Institute on Drug Abuse, part of the National Institutes of Health, has awarded the University of California, Irvine School of Medicine, a 4-year, $9 million grant aimed at determining the long-term impact of cannabis exposure on the adolescent brain.
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D, the company's controlled-release latanoprost insert for the treatment of glaucoma.
The GOP vice presidential candidate made these comments while speaking to a conservative audience at the Values Voter Summit in Washington, D.C. Meanwhile, Planned Parenthood was quick to hit back.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle M Lizotte, MD Po Box 978, Big Timber, MT 59011-0978 Ph: (406) 932-7100 | Michelle M Lizotte, MD 225 Big Timber Loop Rd, Big Timber, MT 59011-7646 Ph: (406) 932-7100 |
News Archive
Olympic athletes inspire us with their fierce discipline and natural talent as they smash records, going higher, further and faster. Their can-do spirit encourages us all to take on new challenges.
Hospital-acquired infections are a huge public health burden, and hospital environments play a key role in harboring potentially deadly bacteria such as E. coli, C. difficile and methicillin-resistant Staphylococcus aureus.
The National Institute on Drug Abuse, part of the National Institutes of Health, has awarded the University of California, Irvine School of Medicine, a 4-year, $9 million grant aimed at determining the long-term impact of cannabis exposure on the adolescent brain.
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D, the company's controlled-release latanoprost insert for the treatment of glaucoma.
The GOP vice presidential candidate made these comments while speaking to a conservative audience at the Values Voter Summit in Washington, D.C. Meanwhile, Planned Parenthood was quick to hit back.
› Verified 8 days ago
Wallace Chester Walker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 West 7th Ave, Big Timber, MT 59011 Phone: 406-932-4199 Fax: 406-932-5490 |